These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cardio-energetic heart therapy]. Beyreder J Wien Med Wochenschr; 1968 Sep; 118(37):717-21. PubMed ID: 5726708 [No Abstract] [Full Text] [Related]
5. Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role. Maseri A; Crea F; Lanza GA Cardiologia; 1999 Feb; 44(2):115-8. PubMed ID: 10208047 [No Abstract] [Full Text] [Related]
6. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
7. Recent advances in drug therapy for coronary artery disease. Waters DD Can Med Assoc J; 1985 Mar; 132(6):625-7. PubMed ID: 2858259 [No Abstract] [Full Text] [Related]
9. [Use of antithrombotic drugs in internal medicine]. Vogel G; Huyke R Z Gesamte Inn Med; 1979 Jan; 34(1):28-34. PubMed ID: 373276 [No Abstract] [Full Text] [Related]
10. Tissue-type plasminogen activator for acute coronary thrombosis. Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965 [No Abstract] [Full Text] [Related]
11. [Significance of vasospasm in myocardial infarction (II)--pre- and post-infarction angina and hypersensitivity of the coronary artery to ergonovine]. Yamagishi M; Kodama K; Nanto S; Taniura K; Koretsune Y; Kuzuya T; Tada M; Inoue M Kokyu To Junkan; 1982 Oct; 30(10):1057-65. PubMed ID: 7156520 [No Abstract] [Full Text] [Related]
12. [Action of Carbocromene in acute and chronic coronary insufficiency]. Pieri J; Casalonga L; Dejouhannet S Sem Hop; 1966 Dec; 42():Suppl:5-10. PubMed ID: 4295767 [No Abstract] [Full Text] [Related]
13. [On the clinical use of a new drug in the therapy of coronary insufficiency]. Bracchetti D; Spada E G Clin Med; 1966 Dec; 47(12):1261-82. PubMed ID: 4173047 [No Abstract] [Full Text] [Related]
14. [Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms]. Leschke M; Mecklenbeck W; Strauer BE Med Klin (Munich); 1992 Jul; 87(7):385-9. PubMed ID: 1508119 [No Abstract] [Full Text] [Related]
16. [Therapy of severe coronary insufficiency with Intensain]. Friese G; Eisenbarth D Med Welt; 1968 Sep; 36():1896-904. PubMed ID: 5716633 [No Abstract] [Full Text] [Related]
17. [Angina pectoris and myocardial infarct with normal coronary arteries]. Schmidlin D; Gander M; Nager F Schweiz Rundsch Med Prax; 1986 Oct; 75(41):1200-5. PubMed ID: 3787006 [No Abstract] [Full Text] [Related]
18. [Our experience with a new medication administered orally in the treatment of coronary insufficiency]. Herreman F Sem Hop; 1966 Dec; 42():Suppl:13-8. PubMed ID: 4296253 [No Abstract] [Full Text] [Related]
19. Variant angina in a 6-year-old boy. Lim CW; Hia CP; Chia BL; Quek SC Int J Cardiol; 2007 Jan; 115(1):e24-6. PubMed ID: 17067693 [TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of coronary and myocardial insufficiency]. Krüger K Ther Ggw; 1974 Apr; 113(4):584 passim. PubMed ID: 4832533 [No Abstract] [Full Text] [Related] [Next] [New Search]